Sung Koo Kim

Prof. Sung Koo Kim


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2013 in Brain and Development
Verified
Journal Article
Closed access
SWSaet Byul Wo
Saet Byul Wo
JLJun Hwa Lee
Jun Hwa Lee
YLYong Ju Lee
Yong Ju Lee
TSTae-Jung Sung
Tae-Jung Sung
KLKon Hee Lee
Kon Hee Lee
SKSung Koo Kim
Sung Koo Kim

1 January 2015 in Korean Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
SKSung Koo Kim
Sung Koo Kim
Kim SK. Korean J Pediatr. 2015 Jan;58(1):8-14. http://dx.doi.org/10.3345/kjp.2015.58.1.8

1 December 2015 in Journal of the Neurological Sciences
Verified
Journal Article
Closed access
JPJoon Ha Park
Joon Ha Park
BSBich Na Shin
Bich Na Shin
BCBai Hui Chen
Bai Hui Chen
IKIn Hye Kim
In Hye Kim
JAJi Hyeon Ahn
Ji Hyeon Ahn
Moo-Ho WonMoo-Ho Won
Moo-Ho Won

13 October 2015 in Experimental and Therapeutic Medicine
Verified
Journal Article
Open access
PDF file
JAJi Yun Ahn
Ji Yun Ahn
BYBing Chun Yan
Bing Chun Yan
JPJoon Ha Park
Joon Ha Park
JAJi Hyeon Ahn
Ji Hyeon Ahn
DLDae Hwan Lee
Dae Hwan Lee
SKSung Koo Kim
Sung Koo Kim
Lacosamide, which is a novel antiepileptic drug, has been reported to exert various additional therapeutic effects. The present study investigated the neuroprotective effects of lacosamide against transient cerebral ischemia‑induced neuronal cell damage in the hippocampal cornu ammonis (CA)‑1 region of a gerbil model. Neuronal Nuclei immunohistochemistry demonstrated that pre‑ and post‑surgical treatment (5 min ischemia) with 25 mg/kg lacosamide protected CA1 pyramidal neurons in the lacosamide‑treated‑ischemia‑operated group from ischemic injury 5 days post‑ischemia, as compared with gerbils in the vehicle‑treated‑ischemia‑operated group. Furthermore, treatment with 25 mg/kg lacosamide markedly attenuated the activation of astrocytes and microglia in the ischemic CA1 region at 5 days post‑ischemia. The results of the present study suggested that pre‑ and post‑surgical treatment of the gerbils with lacosamide was able to protect against transient cerebral ischemic injury‑induced CA1 pyramidal neuronal cell death in the hippocampus. In addition, the neuroprotective effects of lacosamide may be associated with decreased activation of glial cells in the ischemic CA1 region.

21 May 2016 in Neurochemical Research
Verified
Journal Article
Closed access
PDF file
HCHyun Young Choi
Hyun Young Choi
JPJoon Ha Park
Joon Ha Park
BCBai Hui Chen
Bai Hui Chen
BSBich Na Shin
Bich Na Shin
YLYun Lyul Lee
Yun Lyul Lee
SKSung Koo Kim
Sung Koo Kim

Verified
Journal Article
Open access
PDF file
YYyoonyoung yi
yoonyoung yi
HSHyo Jung Shin
Hyo Jung Shin
SCSeung Gyu Choi
Seung Gyu Choi
JKJoon Won Kang
Joon Won Kang
HSHEE-JUNG SONG
HEE-JUNG SONG
DKDong Woon Kim
Dong Woon Kim
Neonatal ischemic stroke has a higher incidence than childhood stroke. Seizures are the first sign for the need for clinical assessment in neonates, but many questions remain regarding treatments and follow-up modalities. In the absence of a known pathophysiological mechanism, only supportive care is currently provided. Stroke-induced microglia activation and neuroinflammation are believed to play a central role in the pathological progression of neonatal ischemic stroke. We induced a photothrombotic infarction with Rose Bengal in neonatal rats to investigate the effects of pre- and post-treatment with Aspirin (ASA), Clopidogrel (Clop), and Coenzyme Q10 (CoQ10), which are known for their neuroprotective effects in adult stroke. Pre-stroke medication ameliorates cerebral ischemic injury and reduces infarct volume by reducing microglia activation, cellular reactive oxygen species (ROS) production, and cytokine release. Post-stroke administration of ASA, Clop, and CoQ10 increased motor function and reduced the volume of infarction, and the statistical evidence was stronger than that seen in the pre-stroke treatment. In this study, we demonstrated that ASA, Clop, and CoQ10 treatment before and after the stroke reduced the scope of stroke lesions and increased behavioral activity. It suggests that ASA, Clop, and CoQ10 medication could significantly have neuroprotective effects in the neonates who have suffered strokes.